Abstract
Research in engineered tissue model system focusing on stem cells and tissue engineered constructs for applications in regenerative medicine has driven the discovery and development of new drugs for human disease. In this issue, Tissue Engineering, Part C will launch a Special Collection that highlights the contribution of model systems to the current discovery of innovative drugs across multiple disease areas. The Guest Editors of this
Areas of interest include, but are not limited to:
Modeling human diseases using stem cells, scaffolds and growth factors Modeling human diseases using stem cells and “organs-on-a-chip” for drug discovery Applications of organoid-derived tissue models in drug discovery/screening/delivery Applications of CRISPR/Cas9 modified induced pluripotent stem cells in disease model and tissue engineering Drug screening using human derived organoids Calibration and validation of organoid systems for drug screening applications
Contributions will receive prompt and thorough peer review. Please refer to our Instructions for Authors at www.liebertpub.com/ten before submitting your manuscript for consideration. Authors are encouraged to vet ideas directly with Drs. Chen and Verhaar via e-mail before submitting. Please submit all pre-submission inquiries to Dr. Chen at
Manuscript Submission Deadline:
Editorial questions?
Contact Dr. Ying Chen, Guest Editor, E-mail:
Contact Dr. Marianne Verhaar, Guest Editor, E-mail: